Specificity of the skin test with varicella-zoster virus (VZV) antigen was examined in guinea pigs infected with herpes simplex virus (HSV) type 1 or VZV and in children with a history of HSV infection who developed varicella. Infected guinea pigs responded positively only to homologous virus. No cross-reaction between HSV and VZV was detected in the skin test, as well as in the neutralization test in infected guinea pigs, suggesting that the VZV skin test is specific for immunity to VZV infection. Twelve children were infected with HSV during an HSV epidemic and subsequently developed varicella in institutional settings. During the 2.5-month period between the HSV and VZV infections, the immune status of the children to VZV was negative both in the skin test and in the antibody test, although antibody to HSV was detected by an immune adherence hemagglutination test. After VZV infection, all responded positively both in the skin test and in the antibody test (immune adherence hemagglutination test) to VZV. These results suggest that the VZV skin test is specific for immunity to VZV infection, not cross-reactive to HSV infection in humans. This specificity will be of value in screening susceptibility or immunity to VZV, irrespective of prior HSV infection.
Skin test antigen to varicella-zoster virus (VZV) was developed and first characterized by our group in 1977 (9) . Since then, its utility as a predictor of immunity to VZV has been further documented (1, 3, 6, 8, 9, 11, (16) (17) (18) 20) . It has been successfully used for the follow-up of vaccinees (including adults) of a live varicella vaccine or natural varicella. Its reactivity can be assessed in guinea pigs infected with live varicella vaccine (12, 17, 23) . Although the usefulness of the skin test antigen for screening susceptibility to VZV infection has been documented, little information is available regarding whether the VZV skin test is cross-reactive with herpes simplex virus (HSV) infection, particularly in humans. Recently it has been reported that a VZV glycoprotein (gpII) is cross-reactive with HSV glycoprotein (gB) (4, 5, 10, 15) . This study was designed to clarify the specificity of skin test antigen in relation to HSV infection in experimentally infected guinea pigs and in naturally infected children in institutional settings. (Fig. 1 ). Since one child had a clinical HSV infection just before contracting varicella, no significant rise in antibody to HSV was detected when the antibody appeared in the other 11 cases (Fig. 1A) . Rises in HSV antibody titer were fourfold or more in 2 of 12 children when they had chicken pox after HSV infection. No cross-reactive IAHA antibody to VZV was detected in any of the 12 children during and after HSV infection (Fig. 1B) . VZV skin test reactivity (erythema size in millimeters) in the children remained negative for 2 months after acute herpetic gingivostomatitis, and then it turned positive during and after exposure to epidemic varicella (Fig. 2) . One child, negative at the test, was confirmed positive when tested again 3 months after onset.
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DISCUSSION
The immunological relationship between VZV and HSV is one of the important subjects for serodiagnosis of both viruses. Immune response to either virus infection occasionally causes a rise in heterologous as well as homologous virus antibody titer (21) . This was observed only in patients having prior infection with heterologous virus (13, 14) . Antigenic cross-reactivity was reported by immunofluorescence assay (7) . It was subsequently clarified that major antigenic crossing was present in viral glycoproteins, but that no cross-neutralization of virus was detected with hyperimmune sera (15) . The cross-reactivity of gpII of VZV and gB of HSV in a precipitation test was recently confirmed (4, 5, 10 contains two major glycoproteins with molecular weights of 115,000 and 45,000, and these were different species from the glycoprotein that was cross-reactive with HSV. Positive reactivity of VZV or HSV soluble skin test antigen was observed in guinea pigs immunized with homologous virus, but no cross-reactivity was observed with heterologous virus (17) .
These observations were further confirmed in the present study in infected guinea pigs by using crude skin test antigens prepared from guinea pig embryo fibroblasts infected with either virus containing at least a viral crossreactive glycoprotein. No cross-reaction was observed with cross-reactive crude antigens. This result suggested that the cross-reactive glycoproteins of both viruses could be detectable serologically but not detectable by blastogenic response to viral antigen in a short incubation period (24) 
